JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that the Company’s President and Chief Executive Officer Dr. Jeremy Levin will host a conference call and webcast to discuss his recent transition to CEO, and provide an update on financial guidance for 2012 and general business on Thursday, May 24, 2012 at 8:00 a.m. Eastern Time.
